Statin Use and Risk of Lung Cancer: a Meta-Analysis of Observational Studies and Randomized Controlled Trials

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

(2013)   LANCET

Statin use and risk of breast cancer: a meta-analysis of observational studies

(2012) Krishna Undela et al.   BREAST CANCER RESEARCH AND TREATMENT

Statin use and risk of pancreatic cancer: a meta-analysis

(2012) Xiaobing Cui et al.   CANCER CAUSES & CONTROL

Statins and primary liver cancer

(2012) Danitza Pradelli et al.   EUROPEAN JOURNAL OF CANCER PREVENTION

Atorvastatin synergizes with IFN-γ in treating human non-small cell lung carcinomas via potent inhibition of RhoA activity

(2012) Jie Chen et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Lack of Effect of Lowering LDL Cholesterol on Cancer: Meta-Analysis of Individual Data from 175,000 People in 27 Randomised Trials of Statin Therapy

(2012)   PLoS One

Exposure to statins and risk of common cancers: a series of nested case-control studies

(2011) Yana Vinogradova et al.   BMC CANCER

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Long-term Use of Cholesterol-Lowering Drugs and Cancer Incidence in a Large United States Cohort

(2011) E. J. Jacobs et al.   CANCER RESEARCH

Inhibition of lung cancer growth: ATP citrate lyase knockdown and statin treatment leads to dual blockade of mitogen-activated protein Kinase (MAPK) and Phosphatidylinositol-3-kinase (PI3K)/AKT pathways

(2011) Jun-ichi Hanai et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Lovastatin Sensitizes Lung Cancer Cells to Ionizing Radiation: Modulation of Molecular Pathways of Radioresistance and Tumor Suppression

(2011) Toran Sanli et al.   Journal of Thoracic Oncology

Statin use and the risk of female lung cancer: A population-based case-control study

(2011) Meng-Hsuan Cheng et al.   LUNG CANCER

Atorvastatin reduces vascular endothelial growth factor (VEGF) expression in human non-small cell lung carcinomas (NSCLCs) via inhibition of reactive oxygen species (ROS) production

(2011) Jie Chen et al.   Molecular Oncology

Statin-triggered cell death in primary human lung mesenchymal cells involves p53-PUMA and release of Smac and Omi but not cytochrome c

(2010) Saeid Ghavami et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Simvastatin enhances irinotecan-induced apoptosis in human non-small cell lung cancer cells by inhibition of proteasome activity

(2010) In Hae Park et al.   INVESTIGATIONAL NEW DRUGS

Apoptotic induction by simvastatin in human lung cancer A549 cells via Akt signaling dependent down-regulation of survivin

(2010) Ki-Eun Hwang et al.   INVESTIGATIONAL NEW DRUGS

Reduction of lung metastasis, cell invasion, and adhesion in mouse melanoma by statin-induced blockade of the Rho/Rho-associated coiled-coil-containing protein kinase pathway

(2010) Yasuhiro Kidera et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement

(2010) David Moher et al.   International Journal of Surgery

Statins inhibit NK‐cell cytotoxicity by interfering with LFA‐1‐mediated conjugate formation

(2009) Patrick C. Raemer et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Incidence of cancer and statin usage-Record linkage study

(2009) Jari Haukka et al.   INTERNATIONAL JOURNAL OF CANCER

Lovastatin overcomes gefitinib resistance in human non-small cell lung cancer cells with K-Ras mutations

(2009) In Hae Park et al.   INVESTIGATIONAL NEW DRUGS

The double-edged sword of statin immunomodulation

(2008) Mark R. Goldstein et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments

(2008) Edward J. Mills et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The Association Between Statins and Cancer Incidence in a Veterans Population

(2008) W. R. Farwell et al.   JNCI-Journal of the National Cancer Institute

The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells

(2007) Karin Mausner-Fainberg et al.   ATHEROSCLEROSIS